Christoph Samuel Ziegler bought $33K of Veraxa Biotech stock
By AlphaYouPublished Form 4
Ziegler Christoph Samuel
Reporting filer
Christoph Samuel Ziegler reported buying 30,000 shares of Veraxa Biotech AG - Post de-SPAC for about $33K ($1.09 a share on average). Form 4 filed Oct 21, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 21, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Ziegler Christoph Samuel | 2026-10-20 | P | Purchase | 30000 | 1.09 | 37,932 | 1 day | Filed terms
|
Ordinary Shares
- Owner
- Ziegler Christoph Samuel
- Date
- 2026-10-20
- Code
- P
- Action
- Purchase
- Quantity
- 30000
- Price
- 1.09
- Following holdings
- 37,932
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-10-20
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 30000
- transaction Price Per Share: 1.09
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 37932
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Ziegler Christoph Samuel: Director.
Original sources
Prepared automatically from public filing data. Report a correction.